IGFBP1 and gastric cancer: Sato et al. showed that an increased expression of IGFBP1 was more likely to lead to hematogenous metastasis and exhibited a worse survival, IGFBP1 might be a possible new predictive factor and candidate for molecular targeted therapy in GC (39).